Previous studies of cerebral oxygen metabo lism and extraction in patients with subarachnoid hemor rhage (SAH) have yielded conflicting results. We used positron emission tomography (PET) to measure the re gional cerebral metabolic rate for oxygen (rCMR02), ox ygen extraction fraction (rOEF), and cerebral blood flow (rCBF) 16 times in 11 patients with aneurysmal SAH. All studies were performed preoperatively; no patient had hydrocephalus or intracerebral hematoma on brain CT. Eight patients with no arteriographic vasospasm who were studied on days 1-4 post-SAH had a significant 25% reduction in global CMR02 compared to age-matched controls, and no significant change in global OEF, sug-
The effect of subarachnoid blood on cerebral ox ygen metabolism and the importance of this effect in the pathogenesis of brain dysfunction caused by subarachnoid hemorrhage (SAH) are poorly under stood. Fein has suggested that a direct effect of sub arachnoid blood on cerebral metabolism might be partly responsible for the "encephalopathy" of pa tients with SAH. He injected blood into the cisterna magna of experimental animals and produced re ductions in cerebral oxidative metabolism in the ab sence of ischemia. This reduction occurred even if intracranial pressure was held constant, and was gesting a primary reduction in CMR02 caused by SAH. Four patients studied seven times during arteriographic vasospasm had significantly increased rOEF with un changed CMR02 in arterial territories affected by arterio graphic vasospasm compared to territories without vaso spasm, indicative of cerebral ischemia without infarction. No brain regions studied with PET were infarcted on fol low-up CT. We conclude that the initial aneurysm rupture produces a primary reduction in CMR02, and that sub sequent vasospasm causes ischemia. Key Words: Sub arachnoid hemorrhage-Aneurysm-Cerebral isch emia-Metabolism-Positron emission tomography Humans. thought to be mediated by brainstem structures, since it did not occur when blood was introduced over the cerebral convexity (Fein, 1975 (Fein, , 1976 . Whether such direct depression of metabolism oc curs in humans with SAH is unclear. Several inves tigators have measured either global or regional ce rebral oxygen metabolism (CMR02) in patients with SAH, with disparate findings and interpretations. Some have found depressed CMR02 with normal oxygen extraction (OEF) and interpreted this as ev idence of direct depression (Grubb et aI., 1977; Voldby et aI., 1985) . Others have found increased OEF, suggesting ischemia as the cause of any alter ations in CMR02 (Powers et aI., 1985a) . These dis crepant results are difficult to interpret because of failure to account for several factors that might af fect CMR02 independent of any direct effects of subarachnoid blood. These include hydrocephalus (Ishikawa et aI., 1989) , intracerebral hematoma (Uemura et aI., 1987) , sedative drugs (Siesjo, 1978) , retraction trauma at the time of surgery, and the effect of vasospasm.
In patients with vasospasm following SAH, dif-ferentiating primary metabolic depression from ischemia has been particularly difficult, in large part because the changes in CMR02 produced by isch emia are so variable and time dependant. They can vary from normal CMR02 with increased oxygen extraction in early ischemia, to reduced CMR02 and normal to low oxygen extraction in completed infarction (Wise et aI., 1983; Powers and Raichle, 1985; Correia et aI., 1989; Powers, 1991) . The pur pose of this study was to investigate the effect of aneurysmal SAH on human brain metabolism and oxygen extraction absent confounding factors, both in the early posthemorrhage period and during ar teriographic vasospasm.
METHODS

Subjects
From our laboratory records, we selected all positron emission tomography (PET) studies of regional cerebral blood flow (rCBF), regional cerebral blood volume (rCBV), regional oxygen extraction fraction (rOEF), and regional cerebral metabolic rate for oxygen (rCMR02) performed on patients with aneurysmal SAH. All patients had had at least one brain computed tomography (CT) scan performed during their hospitalization. We then ex cluded studies that were performed in the postoperative period, and those in patients with intracerebral hematoma or hydrocephalus shown on brain CT scan. We also elim inated one patient who had a single PET scan following complete resolution of arteriographic vasospasm and had a left hemiparesis at the time of PET, on the grounds that data from this patient would represent neither the early direct effects of SAH on the brain, nor the effects of ongoing arteriographic vasospasm. This left 16 PET stud ies performed on II patients. Cerebral arteriography was performed within I day of PET in all but two studies. One patient, who underwent arteriography I day post-SAH, had no vasospasm and had a PET study 2 days later. Another, who had arteriography 18 days post-SAH that showed that vasospasm was present, had a PET study 15 days post-SAH. Neither patients' clinical status changed between the time of PET and arteriogram (Table I) . We reviewed the patients' hospital records, and recorded the presence or absence of loss of consciousness or seizure at the onset of SAH, and the opening pressure on the initial lumbar puncture, if done. These were recorded as possi ble indicators of the severity of the cerebral insult pro duced by the initial aneurysm rupture. Since several pa tients in this group were taking phenobarbital prior to PET, the cumulative phenobarbital dose also was re corded for each patient (Table 2) .
PET studies also were performed on 20 normal volun teers, aged 24-75 (mean of 46.3) years, selected as an age-matched control group for the subgroup of patients who had PET scans prior to the onset of vasospasm. Seven of the volunteers, aged 68 to 75 years, were vol unteer participants in the Washington University Mem ory and Aging Project. Each had a clinical interview, gen eral physical examination, standardized 2-h battery of psychological tests, blood and urine tests, and a CT scan of the brain. Only those classified as normal and healthy according to previously published criteria were included in our study (Berg et aI., 1982) . The remaining 13, aged 24 to 50 years, were volunteers who had no history or evi dence of neurologic disease and were recruited by public advertisement. Informed written consent was obtained from each subject or next of kin before all PET measure ments. This protocol was approved by the Human Stud ies Committee and the Radioactive Drug Research Com mittee of the Washington University School of Medicine.
Arteriograms
All arteriograms were reviewed by one of us in addition to reviewing the neuroradiologist's report. All studies were carotid or carotid and vertebral selective arterio grams, filmed in two or more planes of view. Vasospasm affecting the middle cerebral artery (MCA) territory was graded by measuring the arterial caliber of the supraclinoid internal carotid artery (lCA) and M 1 branch of the MCA. Spasm was graded as severe if the caliber of either artery was reduced by greater than 50%, and was graded as mild if spasm was present in either artery, but arterial caliber reduction was less than 50% in both. Control measurements of each artery were obtained by measuring arterial caliber from an arteriogram prior to the onset of arteriographic vasospasm, or by measuring arterial caliber in the unaffected contralateral hemisphere (Grubb et aI., 1977) .
CT scans
All patients had one or more brain CT scans during their hospitalization. All were available for review, ex cept for two scans performed on one patient, done 11 and 18 days post-SAH. Both were read as negative for hydro cephalus by attending neuroradiologists. Available CT scans were reviewed, and the ratio of the maximum dis tance between frontal horns to the transverse brain width was calculated. In all cases, patients' ratios were within two standard deviations of the mean of ratios of neuro logically normal patients (Hahn and Rim, 1976) .
The amount of subarachnoid blood seen by CT was graded by adapting the method of Fisher et al. (1980) . On each patient's initial CT, the thickness of subarachnoid blood collection was measured in the interhemispheric fissure, sylvian stem and cistern, insular cistern, and the suprasellar, interpeduncular, and ambient cisterns. Ap propriate corrections were made for magnification. The amount of subarachnoid blood was considered "large" if bilateral collections greater than 5 mm in thickness were present; otherwise, the amount of blood was considered "small. "
Positron emission tomography
Measurements of rCBF, rCBV, and rOEF were per formed on the PETT VI tomograph in the low-resolution mode with a reconstructed transverse resolution of 18 mm full width at half-maximum (FWHM) (Ter-Pogossian et aI., 1982) . This tomograph collects seven parallel slices, 1.4 cm apart. Venous and arterial catheters were placed to permit radiotracer injection and collection of arterial blood samples. Subjects were positioned so that the lowest tomographic slice was near the canthomeatal line. The head was then immobilized by an individual face mask made of heat-molded plastic and attached to a head rest. A plastic plate with seven radio-opaque wires was used to record the position of each of the seven PET slices on a lateral skull radiograph. A transmission scan with a 68Ge/68Ga ring source was performed for each sub ject to provide data on photon attenuation necessary for quantitative reconstruction of subsequent scans.
Regional CBF was measured after bolus intravenous injection of ISO-labeled water (H2150) (Herscovitch et aI., 1983; Raichle et aI., 1983) . Regional CBV was measured after a brief inhalation of ISO-labeled carbon monoxide (CI50) (Martin et aI., 1987) . Regional OEF was measured after brief inhalation of ISO-labeled oxygen (0150) (Min tun et aI., 1984) . The rCMR02 was calculated as the prod uct of rCBF, rOEF, and arterial oxygen content. The rCBVIrCBF ratio was calculated as an indicator of auto regulatory vasodilation due to reduced perfusion pressure (Gibbs et aI., 1984; Powers et aI., 1987; Sette et aI., 1989) . Subjects' eyes and ears were not masked. The short half life of ISO (122.1 s) allowed these studies to be done in rapid succession. Total study duration ranged from 1 to 2 h. All radiotracers were produced by the Washington University medical cyclotrons (Welch and Kilbourn, 1985) .
There were eight patients, aged 24-70 (mean of 49.9) years, whose initial PET was performed prior to the onset of vasospasm (days 1-4 posthemorrhage). The early ef fects of SAH on global CBF and oxygen metabolism were then evaluated as follows: for each patient's initial PET study, a stereotactic system was used to define 22, 1.43 x 1.43 cm regions of interest, 7 in the cortical territory of each MCA, and 2 each in the cortical territories of each anterior and posterior cerebral artery (Fox et aI., 1985; Powers et aI., 1985b) . The global mean value from these regions was then calculated for CBF, CBV, OEF, CMR02, and CBV/CBF. The same procedure was fol lowed for the studies of the 20 volunteers. One of the eight patients had had two PET studies at different times without spasm on arteriography. Only data from the first study were used in this part of the analysis.
The effects of vasospasm of the ICA and MCA were evaluated by using the stereotactic system to define seven 1.43 x 1.43 cm regions of interest in the cortical territory of each MCA for all patients, and calculating mean values for rCBF, rCBV, rOEF, rCMR02, and rCBVIrCBF for each MCA territory (Fox et aI., 1985; Powers et aI., 1985b) . Since patients in spasm who had follow-up arte riograms sometimes had only unilateral studies, flow and metabolism data from MCA territories for which there was no accompanying arteriographic data were not used. D . . 4. CARPENTER ET AL.
Statistical analysis
Global CBF, CBV, OEF, CMR02, and CBV/CBF in patients with SAH prior to the onset of vasospasm were compared to values in normal volunteers using unpaired t tests. Because this involved five separate tests, we used a Bonferroni correction to maintain the overall type I error rate for this analysis at 0.05. Therefore, the alpha proba bility (p value) we required to declare a difference signif icant was set at 0.05/5, or 0.01 (Wallenstein et aI., 1980) . Statistical testing for relationships between global CMR02 and the amount of subarachnoid blood on CT, the opening pressure on initial lumbar puncture, the pres ence or absence of loss of consciousness or seizure at onset, and the cumulative phenobarbital dose prior to PET was performed with linear regression for continuous variables, and unpaired t tests for categorical variables.
Values for MCA rCBF, rCBV, rOEF, rCMR02, and rCBV /rCBF from patients with SAH were compared in MCA territories with no vasospasm, mild vasospasm, or severe vasospasm with one-way analysis of variance (ANOV A). Since this analysis also required five separate tests, the Bonferroni correction was applied to this anal ysis also. Thus, the alpha probability (p value) we re quired to declare a difference significant was set at 0.05/5, or 0.01. A Newman-Keuls test was used for further post hoc analysis if the ANOV A indicated a significant differ ence between degrees of spasm (Zar, 1984) .
RESULTS
Each patient's clinical characteristics at the time of PET are shown in Table 1 . Day of PET refers to days post-SAH, with the hemorrhage occurring on day O.
Studies prior to vasospasm
Mean values of global CBF, CBV, CMR02, OEF, and CBV/CBF in SAH patients prior to the onset of arteriographic vasospasm and in controls are pre sented in Table 3 . The only significant difference was a 25% reduction in global CMR02 in patients with SAH compared to age-matched controls. While CBF was also reduced in patients, this result did not quite attain the Bonferroni-corrected signif icance level of 0.01. Values for CBV, OEF, and CBV/CBF were unchanged. The relationship between individual patients' global CMR02 and several clinical variables is noted in Table 2 . Five of the eight patients in this group were taking phenobarbital for 0-3 days prior to PET. Since phenobarbital can reduce CMR02 in humans when administered in sufficient doses (Siesj6, 1978) , the potential relationship between cumulative phenobarbital dose and CMR02 was in vestigated with linear regression analysis. No rela tionship was found (p = 0.49, ? = 0.08). No rela tionship was found between global CMR02 and loss of consciousness or seizure at onset of SAH, amount of subarachnoid blood seen on initial CT, or opening pressure on initial lumbar puncture.
Studies during vasospasm
Four patients had a total of seven PET scans per formed during arteriographic vasospasm; associ ated focal neurologic deficits were present during six of these scans. Values of rCBF, rCBV, rCMR02, rOEF, and rCBV/rCBF in patients' MCA territories with no vasospasm, mild vasospasm, and severe vasospasm are shown in Fig. 1 . There was a significant elevation in rOEF in MCA territories af fected by arteriographic vasospasm. Mildly affected MCA territories had significantly increased rOEF over territories without vasospasm, and severely af fected MCA territories had significantly increased rOEF over both unaffected and mildly affected ter ritories (all p < 0. 005, Newman-Keuls test). A sim ilar stepwise reduction in rCBF also occurred in territories with vasospasm, although this did not quite reach the Bonferroni-corrected significance level of 0. 01. The rCBV /rCBF ratio showed a step wise increase with increasing spasm, but again this was not significant. There was no significant change in rCMR02.
We reviewed all available final brain CT scans for the patients with arteriographic vasospasm. None demonstrated infarction in the cortical MCA terri tory. Patient #2 had a normal final CT 20 days post SAH, and had a normal neurologic examination at discharge. Patient #5 had her final CT 42 days post SAH, which showed bilateral anterior cerebral ar tery distribution infarcts, and right caudate infarc tion sparing the cortical MCA territory. She was discharged on day 43; her neurologic exam showed bilateral leg weakness and mild right arm weakness. Patient # 10 had a final CT 20 days post-SAH, which was not available for review. It was inter preted as showing a right basal ganglia infarction, sparing the cortical MCA territory. She was dis charged 39 days post-SAH, with trace left arm weakness noted on examination. Patient # 11 had his final CT 50 days post-SAH. No infarction was to multiple comparisons, the p value required for statistical significance is p = 0.01 CBV (see the text). CBF: cerebral blood flow;
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ml/100g CMR02: cerebral metabolic rate for oxygen; OEF: oxygen extraction fraction; CBV: cere- o. p = 0.40 noted, and at discharge he had mild left hand clum siness and minimal left facial weakness.
DISCUSSION
We have used PET to study the effects of SAH and subsequent arteriographic vasospasm on cere bral oxygen metabolism and oxygen extraction in a group of unoperated patients, none of whom had either intracerebral hematoma or hydrocephalus. We eliminated patients with these conditions to avoid confounding effects on cerebral oxygen me tabolism.
Early effects of SAH
In patients with SAH studied prior to the onset of arteriographic vasospasm, we found a significant 25% reduction in global CMR02. A similar global reduction in CBF also occurred with no change in OEF. Together, these findings indicate a primary reduction in CMR02, with a secondary reduction in CBF due to the reduced metabolic demands of the brain (Baron, 1985; Frackowiak, 1985; Powers and Raichle, 1985) . A legitimate concern may be raised concerning our use of arteriography to identify pa tients without vasospasm, since delays between the time of arteriography and PET could have allowed development of vasospasm in some patients. We do not think this was the case, as the delays were rel atively short (0 days in three patients, 1 day in four patients, and 2 days in one patient) and no clinical deterioration occurred in any patient between arte riography and PET. Our findings agree with those of Grubb et al. (1977) and Voldby et al. (1985) , both of whom found reduced mean hemispheric CMR02 and CBF in pa tients with SAH in the absence of vasospasm. Nei ther study reported values for OEF, although the patients studied by Voldby et aI. had reductions in the cerebral arteriovenous difference for oxygen (A VD02, mathematically equal to the OEF times the arterial oxygen content). Both studies con cluded that there was a direct effect of SAH on CMR02, the mechanism of which was unknown.
In a PET study of postoperative patients studied 7-18 days after SAH, Hino et aI. (1989) also found reduced rCMR02 and normal rOEF in arterial ter ritories unaffected by vasospasm, but in association with significantly increased rCBF. The increase in rCBF, which occurred despite the reduction in CMR02, may have been due to the fact that their patients were all treated with intravenous colloid in order to maintain a state of isovolemic or hyper volemic hemodilution. All had significantly reduced hematocrit and arterial oxygen content compared to controls, suggesting that this may have been the cause of the increased rCBF that they observed (Brown et aI., 1985) .
Two studies of patients with SAH have found no difference between the CMR02 of patients with SAH and those of controls. Ishikawa et al. (1989) studied rCBF, rOEF, and rCMR02 in seven pa tients with SAH and without hydrocephalus. No significant decrease in rCMR02 was found. Their patient population differed from ours, since they were studied an average of 26 days after hemor rhage, and no data regarding previous or current arteriographic vasospasm was presented. Powers et al. (1985a) studied four patients with SAH with PET, three of whom had studies done prior to the onset of vasospasm. Values for rCMR02 and rCBF were in the low normal range. The number of pa tients in this study was too small to permit mean ingful statistical analysis.
There are several mechanisms by which patients with SAH might develop early reduced global CMR02 in the absence of vasospasm. Such patients are frequently sedated with phenobarbital, as was the case with five of our patients. Barbiturates are well known for causing depression in CMR02 when used in anesthetic doses (Siesj6, 1978) , although acute doses of up to 500 mg of phenobarbital given intramuscularly have been shown to have no effect on CMR02 (McCall and Taylor, 1952) . Since our patients received considerably less than this amount, and since there was no significant relation ship between cumulative phenobarbital dose and global CMROz, we do not think that the reduced CMR02 in our patients was due to phenobarbital. The rapid increase in intracranial pressure (ICP) caused by acute SAH is also a potential cause of the early reduced CMR02 seen in our patients (Nornes, 1978; Grote and Hassler, 1988) . If this increase was sufficiently severe and prolonged, global ischemic injury could result, causing reduced CMR02 that would persist even after cerebral perfusion was re stored as ICP returned towards normal. If this were the mechanism of CMR02 reduction in our patients, then the degree of reduction might be greater in patients with clinical manifestations of more severe initial global ischemia such as loss of consciousness or seizure at the time of hemorrhage. We found no such association in our patients, nor did we find an association between CMR02 and ICP on presenta tion, as measured by lumbar puncture. Thus, our data do not support global ischemia at the time of SAH as a cause of the early reduced CMR02, al though this possibility cannot be entirely ruled out. Fein (1975 Fein ( , 1976 ) postulated a direct effect of sub arachnoid blood on cerebral oxygen metabolism. He suggested that this effect was possibly mediated through a brainstem mechanism, since cerebral ox ygen metabolism was reduced without producing ischemia when blood was injected into the cisterna magna of experimental animals, but not when intro-J Cereb Blood Flow Metab, Vol. 11, No, 5, 1991 duced over the cerebral convexity, How subarach noid blood might cause this reduction is not known. However, in vitro studies of dissociated rat brain cells have shown that a concentration of 10% serum in the culture medium can reduce oxidative glucose metabolism by 60 to 86% (Tildon and Stevenson, 1984; Tildon et aI., 1987) . In our patients, there was no relationship between the size of the subarach noid blood clot seen on initial brain CT (a crude measure of the quantity of subarachnoid blood) and the reduction in global CMR02• This could be due to a "threshold effect, " whereby amounts of blood in excess of that required for maximum reduction in CMR02 produce no additional reduction. Our data demonstrate a direct, primary reduction in global CMR02 in SAH patients, which occurs indepen dently of hydrocephalus, intracerebral hematoma, arteriographic vasospasm, or surgical manipulation, but cannot resolve its mechanism.
Effects of vasospasm
In patients with arteriographic vasospasm, we have found evidence of increasing MCA territory ischemia associated with increasing degrees of va sospasm. This is indicated by the pattern of rising rOEF, accompanied by trends in decreasing rCBF and rising rCBV/rCBF, with preserved CMR02 (Baron, 1985; Frackowiak, 1985; Powers and Raichle, 1985; Powers, 1991) . Our results contrast with several previous studies of rCMR02 in patients with vasospasm due to SAH. Most of these studies have found reduced regional or mean hemispheric CMR02 in patients with arteriographic vasospasm, with the greatest reductions occurring in the pres ence of severe, diffuse vasospasm (Grubb et aI., 1977; Koike et aI., 1981; Voldby et aI., 1985; Jakob sen et aI., 1987 a," Hino et aI., 1989 . The results of simultaneous measurements of either rOEF or A VD02 have been variable from study to study. Jakobsen et al. (1987b) and Voldby et al. (1985) both found no differences in A VD02 in their patients with no vasospasm, focal vasospasm, and severe diffuse vasospasm. Hino et al. (1989) , in a PET study of patients with SAH, similarly found no sig nificant change in the rOEF between territories un affected or affected by arteriographic vasospasm, although they noted that their patients with vaso spasm whose neurologic deficits were progressive at the time of PET had higher mean rOEF than those whose deficits had already peaked in severity. Powers et al. (l985a) studied four SAH patients with arteriographic vasospasm, and found that three had increased rOEF above baseline during ar teriographic vasospasm, while one patient's rOEF was slightly decreased.
The failure of several studies to find increased oxygen extraction in the presence of arteriographic vasospasm has been difficult to reconcile with the prevailing theory that vasospasm exerts its effects on the brain solely by producing ischemia. The lack of increased oxygen extraction in patients with va sospasm has led some to suggest that these patients' reductions in CBF may be due to a nonischemic depression of CMR02, rather than vasospasm (Ja kobsen et al., 1987b) . We believe that the major reason for this apparent discrepancy lies with the time course of changes in oxygen extraction and CMR02 in cerebral ischemic infarction. If CBF falls as a result of reduced cerebral perfusion pressure, CMR02 is initially maintained by a compensatory elevation of OEF. PET studies of patients with isch emic stroke have found elevated OEF in the terri tory of the infarct in 80-100% of patients studied within � 12 h of onset (Baron et al., 1983; Wise et al., 1983; Correia et al., 1989) . Later in the time course of the infarct, a fall in the OEF is seen (Baron et al., 1983; Wise et al., 1983) . Thus, studies of patients with cerebral ischemia or infarction due to vasospasm might or might not find elevated OEF in affected territories, depending on when in this time course their patients were studied. Of the three studies (Voldby et al., 1985; Jakobsen et al., 1987b; Hino et al., 1989 ) that found no difference in A VD02 or OEF between patients with and without arteriographic vasospasm, two reported the out comes of their patients, one noting that 11 of 15 of their patients with severe vasospasm eventually de veloped cerebral infarction (Voldby et al., 1985) , and the other noting that 6 of their 9 patients with symptomatic vasospasm were moderately or se verely disabled at 3 months, also consistent with cerebral infarct (Hino et al., 1989) . In addition, Hino et al. noted that their patients with vasospasm whose neurologic deficits were progressive, indicat ing ongoing ischemia, had elevated rOEF compared to those whose deficits had already peaked, who were therefore probably studied later in the course of cerebral infarction. By contrast, none of our pa tients had more than a mild disability at discharge, and none had CT -determined cerebral infarct in the cortical brain regions studied; hence, our data rep resent primarily ischemia without infarction. Taken together, all of this evidence suggests that previous failures to find elevated oxygen extraction in pa tients with arteriographic vasospasm may have been due to inclusion of patients with completed cerebral infarcts, with reduced CMR02 and OEF, rather than a nonischemic depression of metabo lism.
In summary, we conclude that the effect of rup-tured intracranial aneurysms on CMR02 represents the complex interactions of several different fac tors. The initial aneurysm rupture produces a pri mary reduction in CMR02. Vasospasm produces ischemia that may produce further reductions in CMR02 depending on its severity and duration. If present, hydrocephalus, intracerebral hematoma, brain trauma due to surgical retraction, and seda tive drugs may also contribute to depression of ce rebral metabolism.
